Krystal Biotech Stock In The News
| KRYS Stock | USD 179.38 2.01 1.13% |
Our overall analysis of Krystal Biotech's news coverage and content from conventional and social sources shows investors' bearish mood towards Krystal Biotech. The specific impact of Krystal Biotech news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Krystal Biotech's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Krystal Biotech headlines in addition to utilizing other, more conventional financial analysis modules. Check out Krystal Biotech Backtesting and Krystal Biotech Hype Analysis. For more information on how to buy Krystal Stock please use our How to Invest in Krystal Biotech guide.
Krystal |
Krystal Biotech Today Top News and Investor Outlook
Krystal Biotech Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Krystal and other traded companies coverage with news coverage. We help investors stay connected with Krystal headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Krystal Stock performance. Please note that trading solely based on the Krystal Biotech hype is not for everyone as timely availability and quick action are needed to avoid losses.
Krystal Biotech stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Krystal earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Krystal Biotech that are available to investors today. That information is available publicly through Krystal media outlets and privately through word of mouth or via Krystal internal channels. However, regardless of the origin, that massive amount of Krystal data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Krystal Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Krystal Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Krystal Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Krystal Biotech alpha.
Krystal Largest EPS Surprises
Earnings surprises can significantly impact Krystal Biotech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2018-03-12 | 2017-12-31 | -0.23 | -0.26 | -0.03 | 13 | ||
2019-05-06 | 2019-03-31 | -0.33 | -0.29 | 0.04 | 12 | ||
2019-03-12 | 2018-12-31 | -0.23 | -0.27 | -0.04 | 17 | ||
2019-08-05 | 2019-06-30 | -0.32 | -0.37 | -0.05 | 15 | ||
2021-03-01 | 2020-12-31 | -0.59 | -0.53 | 0.06 | 10 | ||
2020-08-10 | 2020-06-30 | -0.47 | -0.37 | 0.1 | 21 |
Krystal Biotech Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Krystal Biotech Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
13th of March 2025
Disposition of 1331 shares by Krishnan Krish S of Krystal Biotech at 179.5466 subject to R... at news.google.com
3rd of March 2025
KRYS Gets Positive CHMP Opinion for EU Approval of Skin Disease Drug at zacks.com
28th of February 2025
Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK for at gurufocus.com
26th of February 2025
Krystal Biotech to Present at TD Cowen 45th Annual Health Care Conference at gurufocus.com
24th of February 2025
Why Krystal Biotech, Inc. is a Top Momentum Stock for the Long-Term at zacks.com
21st of February 2025
Krystal Biotech Receives Overweight Rating from Cantor Fitzgerald at thelincolnianonline.com
20th of February 2025
Krystal Biotech Inc Q4 2024 Earnings Call Highlights Record Revenue and Strategic ... at gurufocus.com
14th of February 2025
Certuity LLC Buys New Holdings in Krystal Biotech, Inc. at thelincolnianonline.com
18th of December 2024
Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Pa... at finance.yahoo.com
Krystal Biotech Investors Sentiment
The influence of Krystal Biotech's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Krystal. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Krystal Biotech's public news can be used to forecast risks associated with an investment in Krystal. The trend in average sentiment can be used to explain how an investor holding Krystal can time the market purely based on public headlines and social activities around Krystal Biotech. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Krystal Biotech's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Krystal Biotech's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Krystal Biotech's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Krystal Biotech.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Krystal Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Krystal Biotech's short interest history, or implied volatility extrapolated from Krystal Biotech options trading.
Additional Tools for Krystal Stock Analysis
When running Krystal Biotech's price analysis, check to measure Krystal Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krystal Biotech is operating at the current time. Most of Krystal Biotech's value examination focuses on studying past and present price action to predict the probability of Krystal Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krystal Biotech's price. Additionally, you may evaluate how the addition of Krystal Biotech to your portfolios can decrease your overall portfolio volatility.